联系电话: 400 008 0586; 0755-82571568
微信扫码:
1.EXECUTIVESUMMARY
ExecutiveSummary
·Introduction
2.MARKETINTRODUCTION
Introduction
·MultipleSclerosis
·ScopeandSegmentation
·ResearchMethodology
DiseaseOverview
·CausesofMultipleSclerosis
·ClassificationofMultipleSclerosis
·TreatmentOptions
MarketOverview
·MarketEngineeringMeasurements
·MarketTrends
3.MARKETANALYSIS
ProductAnalysis
·Interferons
·Copaxone
·Tysabri
·Novantrone
·PipelineDrugs
PatientForecasts
·TotalPatientForecasts
·PatientForecastbyProduct
RevenueForecasts
·TotalMarketRevenueForecasts
·RevenueForecastsbyProduct
CompetitiveAnalysis
·CompetitiveStructure
·CompanyMarketShare
CompetitveMetrics
·MethodologyandMetrics
·BiogenIdec
·TevaPharmaceuticals
·EMDSerono
·BayerScheringPharma
·EmergingCompanies
4.DECISIONSUPPORTDATABASES
DemographicIndicators
·TotalPopulation
MarketIndicators
·WorldMultipleSclerosisPrevalence
·U.S.MultipleSclerosisPrevalence
·U.S.MultipleSclerosisIncidence
·PharmaceuticalR&DExpenditure
This research service provides revenue forecasts, market shares, projected prevalence and treated populations, market trends, and existing and emerging therapeutics. There is a competitive and product analysis of the major market participants and products with competitive metrics for major and emerging companies.